Nurse practitioners and physician assistants report a high level of independence and broad responsibilities in rheumatology practice, and may help to reduce shortages in the rheumatology workforce, according to a study published in the July issue of Arthritis Care & Research.
Based on hypothetical scenarios, rheumatoid arthritis (RA) patients would accept treatments with lower efficacy and greater risk to achieve lower duration and frequency, according to research published in the July issue of Arthritis Care & Research.
The risk of hospitalized bacterial infections in older rheumatoid arthritis patients is similar for rituximab or abatacept compared to etanercept, although it is higher for infliximab, according to a study published in the July issue of Arthritis Care & Research.
Although tumor necrosis factor inhibitors have dramatically improved management strategies for autoimmune disorders such as rheumatoid arthritis and inflammatory bowel disease, the biologic agents also pose a number of significant side effects that physicians must consider.
The US Food and Drug Administration recently announced its approval of a new medication for the treatment of rheumatoid arthritis.
Melanocortin receptor type 3 has protective properties for joint and periodontal tissues, according to a study published in the August issue of the American Journal of Pathology.